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Cumulative Effects from Repeated Exposures to mtraviolet Radiation 
KAYS H. KAIDBEY, M.D., AND ALBERT M. KLIGMAN, M.D., PH.D. 
Repeated exposures to subliminal doses ofUVR, given 
at 24-hr intervals, resulted in a lowering of the erythema 
threshold dose. At erythemogenically equivalent doses, 
UV-A was the most effective and UV-C the least. A 
similar and more pronounced effect was observed fol-
lowing repeated exposures to subthreshold doses of UV-
A and topically applied 8-methoxypsoralen. These find-
ings provide quantitative evidence for the cumulative 
nature of acute UVR damage in human skin. 
It is gener a lly believed that the changes associated with 
chronic actinic damage arise from cumula tive injury·to the skin 
after many years of repeated exposure to sunlight. Experimen-
tal, clinical and epidemiologic evidence strongly implicate UVR 
as the r esponsible wavelengths. Y e t, with the exception of 
experimental photocarcinogenesis in rodents, there is little 
quantitative information concerning long-term cumulative 
UVR injury, in contrast to acute effects. Chronic ch anges are 
understandably difficult to measure and quantify [1]. The de-
termination of dosage requirements or action spectra for the 
production of keratoses, atrophy and elastotic degeneration, for 
example, would pose considerable problems which are com-
pounded by the lack of adequate experimental animal models. 
The mechanism(s ) that lead to the development of cumula-
tive effects following repeated UVR injury are unknown, al-
though several factors could be involved , such as the production 
of m ediators, changes in the optical properties of the skin as 
well as interference with normal repair processes. It should, 
nonethele~s, be possible to demonstrate this phenomenon with 
repeated exposures to UVR over relatively short time intervals. 
This may enable some qua ntitative measurements to be made 
of the dose levels required for a "build-up" effect, and' may 
provide a n indirect m eans for evaluating the efficiency of UVR-
repair m echanisms in the skin. Furthermore, such studies may 
h ave some clinical relevance. The beneficial effects of several 
phototherapeutic regimens rests on repeated exposures to UVR, 
yet there is no quantitative information regarding these effects. 
The present study was undertake n to determine whether 
. cumulative effects can arise from r epeated exposures to thresh-
old and subthreshold doses of UVR. 
MATERIALS AND METHODS 
Subjects 
These were healthy Caucasian volunteers of both sexes between the 
ages of 18 and 28 yr. The previously exposed but untanned midback 
was the test site. Skin typing was based on sunburning and tanning 
histories [2]. Skin type I always burns, but never tans; skin type II 
always burns, sometimes tans; skin type III sometimes burns and 
always tans. None of the participants were taking any oral or using 
topical medicaments. Informed consent was obtained. 
. Radiation Sources and Radiometry 
Solar simulated radiation was obtained from a 150-w Xenon arc solar 
simulator equipped with a Schott we 320 (1 mm) and a ue 11 (1 mm) 
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fIlters. This provided a continuous spectrum from about 290 nm to 410 
nm, as described previously [3). Longwave ultraviolet (UV-A) was 
obtained from the same source by fIl tering the radiation through a 1-
mm Schott we 345 fIlter to obtain a continuous spectrum between 320 
and 410 nm. The irradiated field was a circle measuring 1 cm in 
diameter. 
Short wavelength ultraviolet (UV-C) was obtained from a hand-held 
contact-type low-pressure cold quartz mercury lamp (Fischerquartz). 
Over 90% of the UV emission from this source is around 254 nm. The 
irradiated field was a 2.5 cm circle. 
Irradiance measurements of broad UV-wavebands were made with 
calibrated, cosine-corrected photodiode-type detectors using an Inter-
national Light model IL 700 research radiometer. For UV-A, a model 
SEE-OlO detector equipped with an interference fIlter with response 
from 300 to 400 nm was used (Peak transmission at 365 nm and half-
power bandwidth of 50 nm). The UV-B detector was model SEE-240 
photodiode and in terference fIlter with response from 270 to 320 nm 
(peak transmission at 297 nm and half-power bandwidth of 25 nm) . 
UV-C and total flux at skin level from the solar simulator were 
measured by calibrated Eppley thermopiles attached to a Keithly 
millimicrovoltmeter . UV-C measurements were made from thermopile 
readings taken with and without a I -mm Schott we 305 (50% cut-off 
at about 294 nm) . AU calibrations were traceable to the National 
Bureau of Standards. Irradiance at skin level from the solar simulator 
was 85.84 mw/cm", with 96% of the energy <400 nm; UV-B was 1.36 
mw/cm2 and UV-A 38.6 mw/cm2; UV-C irradiance was 1.36 mw/em2 • 
Experiments 
The threshold dose for delayed erythema from UV -C, solar simulated 
radiation and UV -A was individually determined by administering a 
series of exposures in 25% increments. The smallest dose required to 
produ ce erythema 24 hr later was the MED. Since the erythema 
produced from solar simulated radiation is due to UV-B «0.5 J /cm2 
UV-A per average MED), this radiation will be referred to as "UV-B." 
Repeated Exposures to UVR 
Designated sites were outlined with ink (permanent felt-tip marker) 
and exposed to 0.25, 0.5, 0.75 and 1 times the MED ofUV-C, UV-B and 
UV-A. In addition, one site received 0.15 MED of UV-A. Exposures 
were given once every 24 hr for 5 consecutive days (Monday through 
Friday) and the sites visually graded for the presence and intensity of 
erythema before each exposure. Thirty-two volunteers completed this 
study. 
In another group of 10 volunteers, similar exposures as described 
above were given every 48 h1" for a total of 5 exposures at each dose 
level. 
Photo toxicity to 8-Methoxypsoralen (8-MOP) 
0.01% 8-MOP in equal parts of acetone and absolute ethanol was 
applied to marked sites at a dose of 5 I'L/cm2 . One hour later, the sites 
were exposed to increasing doses of UV-A (25% increments) . The 
smallest dose required to produce erythema 72 hr later was the mini-
mum phototoxic dose (MPD). Five horizontal rows, each with 3 sub-
sites, were outlined with ink on one side of the back. One subsite within 
each row was exposed to 0.25, 0.5 and 0.75 times the MPD respectively 
once every 24 hr for 5 consecutive days. All 5 rows were exposed on the 
1st day, 4 rows on the 2nd day 3 on the 3rd day and so forth, so that the 
last row received a total of 5 exposures, and the 1st row only one. 8-
MOP was applied 1 hr prior to exposure. 
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RESULTS 
Minimal Erythema Dose 
Table I shows the mean MED ± SD for each waveband in 
each skin type group. The mean MED for UV-A and UV-B was 
lower in skin type I compared to skin type III but this was 
significant (P < 0.05, Student's t-test) only for UV-B. 
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Repeated Exposures at 24-hr Intervals 
The percentage of individuals developing erythema at each 
dose level and after each exposure is shown in Fig 1. Repeated 
exposures to subthreshold doses resulted in the development of 
erythema, although the 3 wavebands differed markedly in their 
effectiveness. Thus repeated exposures to 0.25 MED of UV-A 
produced erythema in about 30% of the individuals after the 
5th exposure (cumulative dose 1.25 MED's), whereas no ery-
thema developed following exposures to UV-B or UV-C at this 
dose level. The effectiveness at erythemogenicaliy equivalent 
energies of each waveband in producing cumulative erythema 
can be seen more clearly in Table II. At the 0.5 MED level, 78% 
developed erythema with UV-A, 50% with UV-B and only 6% 
did so with UV-C. There were no apparent differences between 
the various skin types. 
In Fig 2, the frequency of erythema was plotted against the 
total cumulative dose for each waveband. The response is 
clearly dose-related in an abnost linear fashion. Again it can be 
seen that at equivalent erythemogenic doses, UV -A produced 
the highest response rate, and UV-C the least. 
The erythema usualiy became progressively more intense 
after repeated expOSUl"es, especially with UV-A and UV-B. 
Seven subjects (2 skin type I; 4 skin type II and 1 skin type III) 
developed intense edema and erythema at the 0.75 MED and 
1.0 MED sites with UV -A after the 3rd exposure. Edema was 
not seen with UV-B or UV-C. Pigmentation developed consist-
ently in skin type II and III individuals with UV -A by the 
second exposure and in many instances after the 1st exposure. 
The pigmentation, which lasted for the entire study period also 
became progressively more intense with repeated exposures. 
The lowest effective dose for delayed melanogenesis with UV-
A was 0.25 MED. Thirteen of the 32 subjects developed pig-
mentation at this dose level. Only 3 skin type III subjects 
developed pigmentation at the 1 MED level with UV -C after 
the 5th exposure. No pigmentation was evident with UV-B at 
the end of the 7 -day study period. 
Repeated UVR expOSUl"es at 48-hr intervals resulted in far 
fewer reactions. No erythema developed with subthreshold 
doses of UV-C. Only 2 of 10 subjects had erythema with UV-B 
and UV-A at the 0.75 MED dose level after the 4th exposure, 
but no erythema was seen in any at lower dose levels. Pigmen-
tation following UV-C and UV-A was similar to that described 
above for the 24-hr ex~osures. In 4 cases however, pigmentation 
also developed follOWIng UV-B at the 0.75 and 1.0 MED sites. 
TABLE I. Threshold doses (or delayed elytherna (Mean ± SD) 
Skin type UV-C UV-B (Solar simulated ra- UV-A 
mJ / cm' diation) mJ / cm' J / cm' 
I (n - 10) 
II (n = 11) 
III (n = ll) 
100 
11.6 ± 3.6 
15.5 ± 3.3 
12.0 ± 2.8 
15.1 ± 5.9 
20.5 ± 5.8 
20.3 ± 4.7 
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Phototoxicity with 8-MOP 
Eight of 10 subjects developed erythema at the lowest dose 
level (0.25 MPD) after the 5th expOSUl"e. In 3 instances ery-
thema was evident after the 3rd exposw·e. At Im'ger doses, (0.5 
and 0.75 MPD) all 10 subjects developed erythema which 
generally appeared by the 2nd or 3rd exposure and became 
progressively more intense. 
DISCUSSION 
Our findings clearly demonstrate the cumulative nature of 
acute UVR injury to the skin as determined by a lowering of 
the erythema threshold dose with repeated expOSUl"e. The dos-
ages required were lower than we had anticipated. FUl"thermore 
there were important differences between the major UVR 
wavebands. It is well known that UV-C, UV-B, and UV-A differ 
qualitatively and quantitatively in their biologic effects such as 
the induction of erythema, tanning and cm·cinogenicity. It is 
also apparent that these wavelengths differ in their capacity to 
produce cumulative damage. Thus at erythemogenically equiv-
alent doses, UV-A was more effective than UV-B, and UV-B 
more so than UV -C. These differences may be related to the 
penetration characteristics of these wavelengths. In general, 
transmission of the skin increases with increasing wavelength 
[4]. About 35- 50% of UV-A is transmitted by Caucasian epi-
der~is as compared to 10-30% of UV-B [4,5]' The more pene-
tratmg .UV-A m~y produce greater vascular injury to deeper 
vessels In the COrium. Histologically, the most prominent alter-
ations following both single and repeated exposw'es to UV-A 
are seen in and around the vascular structUl"es [6,7]. This is in 
marked contrast to the pronounced epidermal damage that 
occurs following exposure to UV-B or UV-C. The latter wave-
lengths are probably primarily absorbed by the epidermis. 
Hence although equivalent erythemogenic doses were used, it 
may be that the tm'gets involved are different. This is also 
supported by the observation that intense edema occasionally 
developed with UV -A but not with the other wavebands. 
An alternative explanation for the observed differences men-
tioned above may be that the damage produced by the major 
UV wavebands is repaired by different mechanisms. Whatever 
these may be, it is clem' that UV-A damage is not as efficiently 
repaired as that produced by other wavelengths. We believe 
that these fIndings support the notion that UV-A plays an 
important role in the induction of dermal degenerative change 
observed in "actinicaliy damaged skin [8]. 
Since cumulative effects were observed from repeated expo-
sures given at 24-hr intervals, it is clem' that a longer time 
period is required to repair damage from single subthreshold 
exposures to UVR; probably 48 tu for doses of half an MED or 
greater and possibly longer for UV -A. Damage from lower 
doses, e.g., 0.25 MED is probably repaired within 24 hr. It is 
also to be expected that with the time intervals used in this 
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TABLE II. Frequency of erythema in various shin types following 
exposure to 0.5 MED daily for 4 days 
Skin type UV-C UV-B UV-A 
I (n = 10) 
II (n = 11) 
III (n = 11) 
Total (n = 32) 
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FIG 2. Dose-response relationship between the total cumulative 
dose in terms of MED's and the frequency of delayed erythema. --
UV-A; - - - - - - UV-B; - - - - - - - - - - UV-C. 
study, dose reciprocity does not hold. In other words, four 0.25 
MED exposures do not add up to an erythema dose, since 
repair mechanisms come into play and interfere with this 
relationship. We are unaware of studies dealing with the time 
limits within which dose reciprocity holds, but this must clearly 
be less than 24 hr. 
It should be stressed that our observations were strictly 
limited to ·erythema as a marker of UVR injury. The dosages 
required to produce cumulative damage to epidermal cells, 
DNA, cell membranes and enzymes are most probably different, 
and likely to be lower than those necessary for the induction of 
erythema. The threshold doses for sunburn cell or pyrimidine 
dimer formation for example, are lower than the erythema 
threshold dose [9,10). 
It is well established that repeated exposures to UVR will 
result in adaptation. Thickening of the stratum corneum and 
stimulation of melanogenesis are at least 2 photoprotective 
mechanisms by which the skin can effectively attenuate the 
. intensity of radiation reaching the viable layers. These changes 
however , require at least several days to become established. 
Nonetheless, with UV-A, pigmentation developed briskly and 
sometimes without latency, at least in skin types II and III, 
which is what we had observed in an earlier study [11). Adaptive 
changes, or possibly other mechanisms, such as induction of 
repair processes may account for the flattening or slight decline 
of some of the curves after the 4th UV exposure (Fig 1). There 
appears to be a much longer latency period for true melanoge-
nesis with UV-B and UV-C as compared to UV-A. This is 
another important biologic difference between the major UVR 
wavebands that has not been sufficiently investigated. Further 
,studies are necessary to confirm our suspicion that different 
mechanisms may be involved in the stimulation of true melan-
ogenesis by different UV wavelengths. 
Our findings have some relevance to phototherapy, where 
UVR is often given on a daily ba$is such as in the Goeckerman 
regimen. It is common practice to begin with a subthreshold 
dose followed by daily increments. Great caution should be 
exercised to prevent severe cumulative photo toxic reactions in 
the normal skin, which is often a factor limiting the amount of 
exposure, especially with aggressive UV-B therapy [12). In this 
instance, however, cumulative effects are desirable and proba-
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bly account for the beneficial effects observed even when sub-
threshold doses are given [13]. 
Phototoxic damage by 8-MOP was strongly cumulative. Since 
in the majority of instances erythema was produced by 0.25 
MPD after 4 exposures, dose reciprocity appears to hold over 
a 24-hr period, in contrast to UVR erythema. It is therefore 
very likely that dark repair of 8 MOP-UVA damage is less 
efficient, as suggested by other in vivo studies in animals [14]. 
The dangers from cumulative phototoxic injury with 8-MOP 
therefore, such as in patients receiving PUV A are far greater 
than with UVR alone. 
The steadily increasing use 'of UVR in medicine and industry 
has necessitated the development of safety standards to prevent 
occupational injury to the eyes and skin. Several standards 
have been proposed and the subject recently reviewed [15). 
Certain of these were developed in the absence of adequate 
biologic data and hence may periodically require revision. The 
actual limits are based on threshold doses to "monochro-
matic" radiation for skin erythema and eye photokeratitis, for 
which a combined or envelope action spectrum has been pro-
posed [16). In 1977, the American Conference of Governmental 
Industrial Hygienists (ACGIH) has set the threshold limit for 
254 nm radiation to 0.25 /Lw/cm2 and to 1 mw/cm 2 for UV-A. 
However, it is clear from the foregoing that if exposure is 
anticipated on a daily or regular basis, then the standards must 
take cumulative effects into consideration, and not only the 
threshold dose in order to limit possible chronic effects. Thus 
the total accumulated dose for a 7-hr work day at the proposed 
irradiance levels would be about 6 mJ/cm2 for UV-C and 25 J / 
cm2 for UV-A. For UV-C, this is about half the mean MED of 
13 mJ/cm 2 (Table I) . Since little or no cumulative effects were 
observed at this level, this would appear to be a safe limit. A 
daily exposure to 25 J/cm2 of UV-A on the other hand, which 
is about one MED, may result in cumulative effects. According 
to our findings, the UV -A daily exposure limit should be re-
duced to about 15% of the MED, or about 4 J/cm2 per day, 
which is the dose level that failed to produce cumulative ery-
thema. However, since these are clearly preliminary findings, 
more studies of cumulative injury are necessary before safety 
limits can be firmly established. 
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Announcement 
The 33rd Annual Meeting of the Pacific Dermatologic Association will be held in Reno, Nevada, 
October 18-22, 1981. Each year the Pacific Dermatologic Association encourages young dermatologists to 
submit essays on original work. The Nelson Paul Anderson Memorial Essay Contest is open to all 
physicians in graduate dermatologic training or those who are not more than five yr out of residency 
training residing in the geographical area of the Pacific Dermatologic Association. Entries must be 
received by the Secretary-Treasurer, Richard B. adorn, M .D., Box 428, Letterman Army Medical Center, 
Presidio of San Francisco, California 94129, no later than July 31, 1981. For further information contact 
Dr. adorn. 
